Azelnidipine is a calcium channel blocker (CCB) primarily used for the treatment of hypertension (high blood pressure). It belongs to the dihydropyridine class of calcium channel blockers and works by blocking L-type calcium channels, leading to the relaxation of blood vessels and improved blood flow. This vasodilatory effect helps lower blood pressure, reducing the strain on the heart and decreasing the risk of cardiovascular complications such as stroke, heart attack, and heart failure. Unlike other calcium channel blockers, azelnidipine has a long-lasting antihypertensive effect with a gradual onset of action, making it effective for maintaining stable blood pressure levels throughout the day. Additionally, its lipophilic nature allows it to exert sustained effects on vascular smooth muscle cells, contributing to better blood pressure control with fewer fluctuations.

One of the key advantages of azelnidipine over other calcium channel blockers is its ability to reduce reflex tachycardia, a common side effect observed with many other CCBs. This makes it a suitable choice for patients who require blood pressure control without significant increases in heart rate. Furthermore, azelnidipine has been found to have antioxidant and anti-inflammatory properties, which may provide additional cardiovascular benefits beyond blood pressure reduction. Studies suggest that it may help improve endothelial function and reduce arterial stiffness, further enhancing heart health. These unique pharmacological properties make azelnidipine an effective and well-tolerated option for long-term hypertension management, particularly in patients with metabolic syndrome or existing cardiovascular risk factors.

Azelnidipine is generally well-tolerated, but like all medications, it may cause some side effects, including dizziness, flushing, headache, and mild swelling (edema), particularly in the lower extremities. However, its slower onset of action helps minimize sudden drops in blood pressure, reducing the likelihood of dizziness or fainting. It is important for patients to take azelnidipine as prescribed and under medical supervision, especially those with pre-existing liver or kidney conditions. Regular monitoring of blood pressure and overall cardiovascular health is recommended to ensure optimal treatment outcomes. Overall, azelnidipine is a highly effective, long-acting calcium channel blocker that provides stable and sustained blood pressure control, improving the quality of life for patients with hypertension while minimizing cardiovascular risks.

Isopropyl-2(3-nitrobenzlidene)acetoacetate

39562-25-9